PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-May-2023 Pharmaceutical financial solution for expensive specialty therapies wins innovation award AscellaHealth
30-May-2023 £7 Million Committed Credit Facility Celadon Pharmaceuticals Plc
30-May-2023 Gold Status for Vetter: Named Best Managed Company for the Fourth Time B3C newswire
30-May-2023 Dr. Rohtash Kumar Joins Veranova as Chief Technology Officer Veranova
30-May-2023 HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting HUTCHMED
30-May-2023 Annual General Meeting of May 25, 2023 – Frédéric Oudéa new Chairman of the Board of Directors Sanofi
30-May-2023 UK’s grand ambition for life sciences hinges on delivery ABPI
30-May-2023 Eckert & Ziegler to Host First Radionuclide Theranostics Forum in Boston, MA Eckert & Ziegler Strahlen- und Medizintechnik AG
30-May-2023 CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update CureVac
30-May-2023 MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular Dystrophy MetrioPharm AG
30-May-2023 selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis selectION, Inc.
30-May-2023 Cantourage Group SE: Research update confirms positive development of Cantourage shares and changes valuation recommendation to “Buy” Cantourage Group SE
30-May-2023 Douglas GmbH: DOUGLAS continues strong growth and profitability improvements in second quarter 2022/23 Douglas GmbH
30-May-2023 Formycon reports results for the first quarter 2023 Formycon AG
30-May-2023 Spexis provides business update and announces financial results for the full year 2022 Spexis AG
29-May-2023 IGEA Pharma N.V.: IGEA to update on strategic refocusing decisions. IGEA Pharma N.V.
26-May-2023 SKAN Group AG informs about the ongoing investigation of the Office of the Attorney General of Switzerland SKAN AG
26-May-2023 DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024 DocMorris AG
26-May-2023 Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting Cosmo Pharmaceuticals N.V.
26-May-2023 Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1 Biophytis